Skip to content

A study of Siravedha therapy and Rohitakadya Churna in Fatty Liver Disease

Comparative Clinical Evaluation of Siravedha and Rohitakadya Churna in Yakrita Vikara Non Alcoholic Fatty Liver Disease - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/113331
Enrollment
40
Registered
2026-07-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K95- Diseases of the digestive system

Interventions

None listed

Sponsors

Uttarakhand Ayurved University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with clinical sign and sympyoms of Yakrit Vikara Having fatty livr Grade 1 and Grade 2 based on USG Liver fuction test showing raised Alanine amino transferase more than 1.5 times the normal limits with or without raised lipid profile and fasting blood sugar level within normal limits

Exclusion criteria

Exclusion criteria: Age below 20 years and over 60 years Known case of chronic renal failure ,ischemic heart disease ,congestive cardiac failure ,liver cirrhosis. Known case of Acquired immune deficiency syndrome pregnancy and lactation prolonged medication for various systemic disorder Known case of Chronic debilitating disease likr tuberculosis ,uncontrolled diabetes mellitus ,severe hypertension ,cancer etc.

Design outcomes

Primary

MeasureTime frame
Subjective criteria The patients will be enquired about their symptoms in the shady like Aruchi Hrillasa Avipaka Daurbalya Udara shoola Asya vairasya AnahaTimepoint: Follow up at interval 4 weeks

Secondary

MeasureTime frame
NillTimepoint: Nill

Countries

India

Contacts

Public ContactDR Alisha

Rishikul Campus Haridwar

praveshk312@gmail.com7417935825

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026